16 reports

  • ADDITIONAL RESOURCES
  • Volatility vs. growth

Fighting the stigma: Rising awareness of eating disorders will boost demand for clinics Abstract Eating Disorder Clinics The Eating Disorder Clinics industry has experienced robust consumer demand for industry services. While there has been a relatively high prevalence of eating disorders,...

  • Clinic
  • Eating Disorder
  • Mental Health
  • United States
  • Forecast

& nbsp; There are only three drugs in active clinical development for eating disorders, with two drugs in Phase II, and one in Phase III.

  • Eating Disorder
  • Mental Health
  • Pathology
  • World
  • Clinical Trial profile. 7 Trial Title
  • Target

Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Appetite (Eating) Disorders clinical trials scenario. This report provides top line data relating to the clinical...

  • Eating Disorder
  • Neurology
  • Therapy
  • World
  • Product Initiative
  • Omeros Corp
  • Binge Eating Disorder - Pipeline by Opiant Pharmaceuticals Inc, H2 2017

Binge eating disorder is the most common eating disorder in adults. ## In addition to being more common than anorexia and bulimia combined, binge eating disorder is the most prevalent eating disorder among adult men. ## VYVANSE is

  • Eating Disorder
  • Mental Health
  • Therapy
  • United States
  • Product Initiative
  • Mar 20, 2017: Opiant Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial Evaluating OPNT001 in Bulimia Nervosa

Jul ##, 2017: Opiant Pharmaceuticals Announces Phase I Data for OPNT## in Development for the Treatment of Alcohol Use Disorder Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, anno

  • Eating Disorder
  • Pharmaceutical
  • United States
  • Company
  • Opiant Pharmaceuticals, Inc.
  • Target
  • Clinical Trial Profile Snapshots

Binge Eating Disorder Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Binge Eating Disorder Global Clinical Trials Review, H1, 2017" provides an overview of Binge Eating Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Binge Eating...

  • Eating Disorder
  • Hormone
  • Mental Health
  • Neurology
  • Shire plc
  • Opiant Pharmaceuticals Inc - SWOT Analysis
  • Opiant Pharmaceuticals Inc - Opportunities

Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and...

  • Eating Disorder
  • Pharmaceutical
  • United States
  • Company Financials
  • Opiant Pharmaceuticals, Inc.

The report focuses on drugs and therapies being evaluated for Binge Eating Disorder treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Clinical Trial
  • Drug Discovery And Development
  • Eating Disorder
  • Mental Health
  • Pathology

Insights into Binge Eating Disorder Pipeline ##.

  • Eating Disorder
  • Mental Health
  • World
  • Featured News & Press Releases
  • lisdexamfetamine dimesylate - Drug Profile

Binge eating disorder is the most common eating disorder in adults. ## In addition to being more common than anorexia and bulimia combined, binge eating disorder is the most prevalent eating disorder among adult men. ## VYVANSE is

  • Eating Disorder
  • Mental Health
  • Therapy
  • United States
  • Product Initiative
  • 4.1 BIBLIOGRAPHY
  • 3.1 DISEASE BACKGROUND

Binge Eating Disorder (BED): Epidemiology Forecast to 2027 Summary In 2017, the 7MM had 197,076 diagnosed prevalent cases of Binge Eating Disorder (BED). Epidemiologists expect the diagnosed prevalent cases of Binge Eating Disorder (BED) in the 7MM to increase to 204,424 cases by 2027, at an AGR...

  • Eating Disorder
  • Mental Health
  • United States
  • World
  • Forecast
  • Official Title
  • LATEST CLINICAL TRIALS NEWS ON BULIMIA NERVOSA

" Bulimia Nervosa is a serious and potentially life-threatening eating disorder for which new treatment options are desperately needed, " said Janet Treasure OBE, PhD, FRCP, FRCPsych, Professor of Psychiatry at King' s College London, and principal investigator of the s

  • Eating Disorder
  • Therapy
  • World
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • Clinical Trial Profile Snapshots

Reddy' s under Fed Condition GDCT## NCT##, ##/ ## Central Nervous System Binge Eating Disorder, Bulimia Nervosa, Depression, Major Depressive Disorder, Obsessive- Compulsive Disorder, Panic Disorders Completed Phase I Interventional fluoxetine

  • Eating Disorder
  • Mental Health
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

## ## ## ## Japan ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Italy Source: GlobalData' s Pharma Intelligence Center Clinical

  • Eating Disorder
  • Hospital
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial Profile Snapshots

Binge Eating Disorder Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Binge Eating Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Binge Eating Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Binge Eating...

  • Eating Disorder
  • Mental Health
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 61 Trial Title
  • Latest Clinical Trials News on Anorexia Nervosa

Perhaps most convincingly, a 2014 study, published in the International Journal of Eating Disorders, was conducted on subjects with " severe" Anorexia Nervosa.

  • Eating Disorder
  • Mental Health
  • Neurology
  • World
  • Product Initiative